Nuevocor closes US$24M Series A Financing to Advance Novel Gen...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SINGAPORE,June18,2021/PRNewswire-AsiaNet/-- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an oversubscribed $24 million Series A financing round. The round was co-led by EVX Ventures and Boehringer Ingelheim ...
Authors: LATEST ASIANET NEWS RELEASES